In line with the Egyptian Drug Authority's (EDA) commitment to enhancing patient safety and protecting public health, the Authority has launched a new service that enables the public to view advertising violations related to pharmaceutical and medical products. This initiative aims to raise awareness and reduce the impact of unauthorized or misleading marketing content.

The service includes examples of advertising violations, such as:

• Unauthorized advertisement for a product registered with the Egyptian Drug Authority: This may include misleading or unapproved marketing claims that could lead to product misuse or expose citizens' health to potential risks. to view the clock the link 

• Advertisement containing misleading marketing claims for a product not registered with the Egyptian Drug Authority: This may result in promoting products that are not subject to EDA oversight or do not meet regulatory requirements. to view the clock the link 

The Egyptian Drug Authority emphasizes the importance of not being led by any unverified or unauthorized advertising or marketing content, and refraining from using any product based on unapproved promotional claims. Furthermore, the EDA calls upon all citizens to help protect the community by reporting any advertisement or marketing content suspected of being non-compliant or lacking EDA authorization through its official reporting channels:

"Inappropriate Advertisement" Service via the official EDA website through:

• Quick Response Link

• Monitoring and Complaints Department Email: pm.complaint@edaegypt.gov.eg

• Egyptian Drug Authority Hotline: 15301

Your participation helps curb the spread of misleading advertisements and promotes the safe, rational use of health products and pharmaceuticals.